Page 7 - Qdel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Qdel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Qdel Today - Breaking & Trending Today

Raymond James Lowers QuidelOrtho (NASDAQ:QDEL) Price Target to $110.00

QuidelOrtho (NASDAQ:QDEL – Free Report) had its price objective trimmed by Raymond James from $130.00 to $110.00 in a report released on Tuesday morning, Benzinga reports. The firm currently has a strong-buy rating on the stock. A number of other brokerages have also weighed in on QDEL. StockNews.com started coverage on QuidelOrtho in a report […] ....

Raymond James , Royal Bank , Quidelortho Corporation , Stonepine Capital Management , Jpmorgan Chase Co , Neuberger Berman Group , Quidelortho Company Profile , Norges Bank , Arrowmark Colorado Holdings , Alyeska Investment Group , Free Report , Moderate Buy , Get Free Report , Berman Group , Mark Colorado Holdings , Capital Management , Ortho Corporation , Transfusion Medicine , Molecular Diagnostics , Quidelortho Daily , Nasdaq Qdel , Lower Price Target ,

QuidelOrtho (NASDAQ:QDEL) Now Covered by StockNews.com

StockNews.com started coverage on shares of QuidelOrtho (NASDAQ:QDEL – Free Report) in a research report report published on Thursday morning. The firm issued a hold rating on the stock. Several other equities analysts have also commented on the stock. JPMorgan Chase & Co. reduced their target price on shares of QuidelOrtho from $91.00 to $85.00 […] ....

Raymond James , Jpmorgan Chase Co , Quidelortho Corporation , Third Bancorp , Advisors Inc , Fifth Third Bancorp , Wealth Strategies Group , Eagle Bay Advisors , Royal Bank , Money Concepts Capital Corp , Free Report , Moderate Buy , Get Free Report , Strategies Group , Concepts Capital Corp , Bay Advisors , Ortho Corporation , Transfusion Medicine , Molecular Diagnostics , Quidelortho Daily , Nasdaq Qdel , Initiated Coverage , Stocknews Com ,

Boston Partners Has $14.43 Million Position in QuidelOrtho Co. (NASDAQ:QDEL)

Boston Partners increased its stake in shares of QuidelOrtho Co. (NASDAQ:QDEL – Free Report) by 8.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 161,255 shares of the company’s stock after buying an additional 13,153 shares during the quarter. Boston […] ....

United States , T Rowe Price Investment Management Inc , Royal Bank , Quidelortho Co , Quidelortho Company Profile , Senvest Management , Exchange Commission , Quidelortho Corporation , Jpmorgan Chase Co , Alyeska Investment Group , Arrowmark Colorado Holdings , Boston Partners , Free Report , Rowe Price Investment Management , Mark Colorado Holdings , Street Corp , Ortho Stock Down , Get Free Report , Ortho Corporation , Transfusion Medicine , Molecular Diagnostics , Visit Holdingschannel , Quidelortho Daily , Nasdaq Qdel , Sec Filings , Hedge Fund Holdings ,